Gimv

📍 Antwerp, BE
🏷️ pe
Website besuchen ↗
Investitionsthese

Gimv partners with ambitious entrepreneurs and management teams focused on sustainable growth and value creation. They aim to build leading companies through internationalization, innovation, revenue growth, digitalization, operational excellence, or strategic buy-and-build pathways. Gimv's approach involves providing access to dedicated and experienced multi-disciplinary teams with deep sector knowledge and a local presence combined with an international outlook. The firm acts as a flexible, evergreen partner with a solid balance sheet, primarily investing directly in companies with equity. This flexibility allows for various investment structures, including buyout, growth, or venture capital (specifically for life sciences), through both majority and minority holdings. Gimv focuses on companies tackling societal challenges in areas like sustainable food and well-being, electrification and energy transition, digitalization and automation, and health and demographics. This includes companies involved in safe and environmentally friendly food production, infrastructure investments for net-zero transitions, technological changes and digital transformation, and solutions for an aging population and shifting healthcare preferences. Gimv is an active shareholder, deeply involved and specialized in their five strategic investment platforms: Consumer, Healthcare, Life Sciences, Smart Industries, and Sustainable Cities. They are committed to supporting businesses that promote long-term consumer well-being while driving positive environmental and social impact. Their investment in Alpine, a consumer hearing protection company, exemplifies their approach to supporting purpose-driven brands benefiting from underlying trends like increased health awareness and a demand for premium reusable alternatives with a strong focus on ESG principles. Similarly, their partnership with Baas Verkley shows commitment to strengthening infrastructure solutions for energy transition.

Investitionsphase
Small to medium-sized companies with growth or venture capital needs (for Life Sciences)

Bevorzugte Reifephase für die erste Finanzierung.

Sektoren & Themen

Consumer, Healthcare, Life Sciences, Smart Industries, Sustainable Cities

Thematische Schwerpunkte und Zielmarktsegmente von Interesse.

Ticketgröße
€5 - €150

Standard-Finanzierungsbetrag pro Runde.

Outreach & Dossier-Analysen

Verifiziertes E-Mail-Muster

[email protected] | [email protected]

Analysen-Scorecard der Investitionsthese

Unser KI-Analyzer hat Portfolio-Unternehmen gescannt und verifizierte Übereinstimmungen berechnet...

Verifizierte Partnerkontakte freischalten

Finde verifizierte E-Mail-Vorlagen, direkt von der KI verfasste Outreach-Texte und berechne Übereinstimmungen mit 1 Klick.

Kostenloses Konto erstellen

Dauert weniger als 30 Sekunden · Keine Kreditkarte erforderlich